En los ltimos aos, el mundo de la medicina ha observado un avance significativo en el tratamiento de la obesidad y el manejo del peso corporal gracias al desarrollo de los anlogos de GLP-1 (a-GLP1 en adelante)
Nutrisense, youll be able to learn how to use your body's data to make informed lifestyle choices that support healthy living
The closest performing GLP-1 medicine in terms of average weight loss is Novo Nordisks CagriSema, an Amylin/GLP-1 dual agonist, which had an average weight loss of 22.7% after 68 weeks in Phase 3 trials
It replaces the insulin your body cannot produce or does not produce enough of
The semaglutide and tirzepatide trials changed that expectation: Semaglutide 2.4 mg once weekly produced average weight loss around 15% at ~68 weeks in adults without diabetes, with a substantial fraction of participants losing 1520% of baseline weight
Fructans present in agave is stimulated GLP-1 production and increased the levels of its precursors